EZYPRO®

· Sigknow Biomedical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EZYPRO®, covering 2022-05-10 to 2022-05-10. Get the full timeline:

Most recent: Clinical Trial Update: An Open-label Study of EZYPRO® in Atrial Fibrillation Detection on ESUS Patients [Phase 4]